Carla Schmitz, M.D., M.Sc., Slivina Bocca, M.D., Ph.D., Sandra Anderson, B.S., Hai Wang, Ph.D., João Sabino Cunha-Filho, M.D., Ph.D., Bhaskara S. Ravi, Ph.D., Sergio Oehninger, M.D., Ph.D.
Volume 101, Issue 3, Pages 874-882, March 2014
To investigate the role of MFG-E8 and its receptor integrin αvβ3 in the attachment of trophoblast cells to the endometrial epithelium.
Experimental in vitro study.
By using a well-differentiated endometrial adenocarcinoma cell line (Ishikawa cells) and choriocarcinoma human trophoblast cells (Jar cells), an in vitro assay mimicking human implantation was established. To investigate the impact of blocking MFG-E8 and integrin αvβ3, we pretreated the cell lines with antibodies against those proteins at different concentrations before the attachment assay.
Main Outcome Measure(s):
Attachment rate of Jar spheroids to the epithelial cell monolayer.
Pretreatment of Ishikawa cells with anti-MFG-E8 antibody caused a dose-dependent and significant inhibition of attachment. On the other hand, pretreatment of Jar spheroids did not result in a significant effect on the attachment rate. Pretreatment of Ishikawa cells as well as Jar spheroids with anti-integrin αvβ3 antibodies resulted in a dose-dependent, significant inhibition of attachment.
This study showed that blocking MFG-E8 and its receptor integrin αvβ3 in Ishikawa cells diminishes Jar spheroid attachment. Moreover, blocking integrin αvβ3 in the trophoblastic cells also diminished their attachment to the Ishikawa monolayer.
Read the full text at: http://www.fertstert.org/article/S0015-0282(13)03434-1/fulltext